125 related articles for article (PubMed ID: 1212805)
1. Modulation of the immune response to transplantation antigens. V. A comparison of the effects of antilymphocytic serum and enhancing alloantiserum on effector mechanisms of allograft rejection.
Zola H
Clin Exp Immunol; 1975 Feb; 19(2):367-76. PubMed ID: 1212805
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
Zola H
Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
[TBL] [Abstract][Full Text] [Related]
3. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
4. Secondary cytotoxic tumor immune response induced in vitro.
Röllinghoff M
J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
[No Abstract] [Full Text] [Related]
5. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
Cruse JM; Whitten HD; Lewis GK; Watson ES
Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
[No Abstract] [Full Text] [Related]
6. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
Schultz RM; Woods WA; Mohr SJ; Chirigos MA
Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of graft rejection by LPS: further evidence for effects on T lymphocytes.
Winchurch RA; Hilberg C; Birmingham W; Munster AM
J Reticuloendothel Soc; 1982 Jan; 31(1):31-42. PubMed ID: 6977643
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
Zola H
Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
[TBL] [Abstract][Full Text] [Related]
9. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
11. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
Jones B; Jones TC
Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
[TBL] [Abstract][Full Text] [Related]
12. Circulating antibodies in allograft recipients.
Revillard JP; Betuel H
Adv Nephrol Necker Hosp; 1975; 5():257-81. PubMed ID: 127522
[No Abstract] [Full Text] [Related]
13. Immune response to an allogeneic progressively growing solid tumor.
Eggers AE
Cancer Res; 1976 Jun; 36(6):2085-9. PubMed ID: 773534
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
McKenzie IF; Snell GD
Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
[No Abstract] [Full Text] [Related]
15. Cell-mediated antitumor immune reactions under syngeneic conditions.
Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
[No Abstract] [Full Text] [Related]
16. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
Kedar E; Bonavida B
J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
[TBL] [Abstract][Full Text] [Related]
17. Role of macrophages in tumour immunity. 3. Co-operation between macrophages and lymphoid factors in an in vitro allograft situation.
Evans R; Grant CK
Immunology; 1972 Nov; 23(5):677-87. PubMed ID: 4673868
[TBL] [Abstract][Full Text] [Related]
18. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro.
Jones B; Jones TC; Roitt IM
Immunology; 1977 Apr; 32(4):591-9. PubMed ID: 415967
[TBL] [Abstract][Full Text] [Related]
19. Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.
Newlands ES; Hay FC; Roitt IM
Clin Exp Immunol; 1978 Feb; 31(2):189-96. PubMed ID: 306324
[TBL] [Abstract][Full Text] [Related]
20. Immune rejection of tumor cells: in vivo significance of anti-tumor in vitro immune reactions.
Levy JP; Leclerc JC
Biomedicine; 1975 Jul; 22(4):249-54. PubMed ID: 776239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
